A Study of LY3200882 in Participants With Solid Tumors
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/5/2019 |
| Start Date: | November 21, 2016 |
| End Date: | May 3, 2021 |
| Contact: | There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
| Phone: | 1-317-615-4559 |
A Phase 1 Study of LY3200882 in Patients With Solid Tumors
The main purpose of this study is to evaluate the safety of the study drug known as LY3200882
in participants with solid tumors.
in participants with solid tumors.
Inclusion Criteria:
- The participant must have histological or cytological evidence of cancer.
- Have adequate organ function.
- Have Eastern Cooperative Oncology Group (ECOG) scale performance status of 0 or 1.
- Are able to swallow capsules and tablets.
Exclusion Criteria:
- Have moderate or severe cardiovascular disease.
- Have a serious concomitant systemic disorder.
- Have acute leukemia.
We found this trial at
6
sites
500 S Preston St
Louisville, Kentucky
Louisville, Kentucky
(502) 852-5555
Principal Investigator: Rebecca Redman
Phone: 502-562-4158
University of Louisville The University of Louisville is a state supported research university located in...
Click here to add this to my saved trials
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
Principal Investigator: Timothy Yap
Phone: 713-563-5844
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
New York, New York 10021
Principal Investigator: Howard Fine
Phone: 646-962-6137
Click here to add this to my saved trials
New York, New York 10016
Principal Investigator: Dimitris Placantonakis
Phone: 212-263-2441
Click here to add this to my saved trials
Newcastle, New South Wales
Principal Investigator: Andre van der Westhuizen
Phone: 61243401581
Click here to add this to my saved trials
San Francisco, California 94143
Principal Investigator: Pamela Munster
Phone: 415-353-7070
Click here to add this to my saved trials